CIDEA and diabetes mellitus: Since CIDEA-null mice have been reported to have a lean phenotype and resistance to diabetes [36], class III lines may represent definitive BA progenitors with certain advantages over fetal or adult-derived BAT cells for potential use in transplantation therapy.